VERTEX PHARMACEUTICALS INC / MA ($VRTX)
Filing Information
| Accession Number | 0000875320-26-000094 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 19, 2026 |
| Document Date | Feb 17, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
6,110
Total Value
$555,345.00
P&L
+inf% (+$2,252,748.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Commercial Officer | Common Stock | โ | Feb 17, 2026 | Grant/Award | 4,962 | $0.00 | $0.00 | 24,490 | Direct | โ | View Details | |
EVP, Chief Commercial Officer | Common Stock | โ | Feb 17, 2026 | Tax Withholding | 1,148 | $483.75 | $555,345.00 | 23,342 | Direct | โ | View Details |